Screening for viral hepatitis among male non-drug-abuse prisoners

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 8, 2006, Pages 969-973

  Liao, Kuan Fu ^a   Lai, Shih Wei ^a   Chang, Wu Long ^a   Hsu, Nan Yung ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

ALAT; Hepatitis; Prison; Tattoo

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; ILLICIT DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PRISONER; RISK FACTOR; STUDENT T TEST; TATTOO;

ADOLESCENT; ADULT; AGED; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PRISONERS; RISK FACTORS; SEROLOGIC TESTS; SOCIOECONOMIC FACTORS; TAIWAN;

EID: 33745712839     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520500535576     Document Type: Article

References (31)

1. http://www.doh.gov.tw/ufile/Doc/S02/9101-eng.xls Accessed November 2005.
2. Chen DS, Wang JT, Chen PJ, Wang TH, Sung JL. Hepatitis C virus infection in Taiwan. Gastroenterol Jpn 1991;26 Suppl 3:164-6.
3. Tsai JF, Chang WY, Jeng JE, Ho MS, Wang LY, Hsieh MY, et al. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol 1993;41:296-300.
4. Tai DI, Chen CH, Chang TT, Chen SC, Liao LY, Kuo CH, et al. Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: role of viral infection. J Gastroenterol Hepatol 2002;17:682-9.
5. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996;276:906-8.
6. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800.
7. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336:1855-9.
8. Wang JT, Wang TH, Lin JT, Lee CZ, Sheu JC, Chen DS. Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan. J Gastroenterol Hepatol 1995;10:454-8.
9. Chang TT, Young KC, Yang YJ, Lai KA, Wu HL, Wu MH, et al. Incidence of post-transfusion hepatitis in Taiwan before and after introduction of anti-HCV testing. Liver 1996;16:201-6.
10. Chang CJ, Ko YC, Liu HW. Seroepidemiology of hepatitis C virus infection among drug abusers in southern Taiwan. J Formos Med Assoc 1998;97:826-9.
11. Chen TZ, Wu JC, Yen FS, Sheng WY, Hwang SJ, Huo TI, et al. Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan. J Med Virol 1995;46:247-51.
12. Li CP, Hwang SJ, Lu CL, Chan CY, Wu JC, Lee FY, et al. Risk factor analysis of patients with chronic hepatitis C in Taiwan. Zhonghua Yi Xue Za Zhi (Taipei) 1996;58:275-80.
13. Wang CS, Chang TT, Chou P. Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan. J Clin Epidemiol 1998;51:733-8.
14. Sun CA, Chen HC, Lu CF, You SL, Mau YC, Ho MS, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 1999;59:290-6.
15. Lee PL, Wang JH, Tung HD, Lee CM, Lu SN. A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan. Trans R Soc Trop Med Hyg 2004;98:367-72.
16. Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain. Rev Esp Salud Publica 1998;72:43-51.
17. Hedouin V, Gosset D. Infection with hepatitis C virus in a prison environment. A prospective study in Loos-lez-Lille, France. Gastroenterol Clin Biol 1998;22:55-8.
18. Guimarães T, Granato CF, Varella D, Ferraz ML, Castelo A, Kallas EG. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection. Braz J Infect Dis 2001;5:111-8.
19. Nyamathi AM, Dixon EL, Robbins W, Smith C, Wiley D, Leake B, et al. Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med 2002;17:134-43.
20. Gates JA, Post JJ, Kaldor JM, Pan Y, Haber PS, Lloyd AR, et al. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia. J Urban Health 2004;81:448-52.
21. Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005;41:177-86.
22. Chang CJ, Lin CH, Lee CT, Chang SJ, Ko YC, Liu HW. Hepatitis B virus markers among drug abusers. Chin J Fam Med 1998;8:28-34.
23. Tennant F, Moll D. Seroprevalence of hepatitis A, B, C, and D markers and liver function abnormalities in intravenous heroin addicts. J Addict Dis 1995;14:35-49.
24. Lai SW, Ng KC, Li CI. Descriptive analysis of HBsAg and HCV antibody prevalence in patients receiving health checkups: a hospital-based study. Mid Taiwan J Med 2004;9 Suppl 1:64-9.
25. Hallinan R, Byrne A, Amin J, Dore GJ. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy. J Gastroenterol Hepatol 2005;20:1082-6.
26. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-4.
27. Howe CJ, Fuller CM, Ompad DC, Galea S, Koblin B, Thomas D, et al. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend 2005;79:389-95.
28. Ko YC, Ho MS, Chiang TA, Chang SJ, Chang PY. Tattooing as a risk of hepatitis C virus infection. J Med Virol 1992;38:288-91.
29. Gyarmathy VA, Neaigus A, Miller M, Friedman SR, Des Jarlais DC. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr 2002;30:448-56.
30. Wang CS, Wang ST, Chou P. Using the prevalence of an elevated serum alanine aminotransferase level for identifying communities with a high prevalence of hepatitis C virus infection. Arch Intern Med 2001;161:392-4.
31. Alter MJ, Seeff LB, Bacon BR, Thomas DL, Rigsby MO, Di Bisceglie AM. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 2004;141:715-7.